Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 116, Issue 37, Pages 18295-18303
Publisher
Proceedings of the National Academy of Sciences
Online
2019-08-27
DOI
10.1073/pnas.1904697116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
- (2019) Peng Guo et al. Science Advances
- Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy
- (2018) Peng Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
- (2018) Ling Li et al. BIOMATERIALS
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Using Atomic Force Microscopy to Predict Tumor Specificity of ICAM1 Antibody-Directed Nanomedicines
- (2018) P. Guo et al. NANO LETTERS
- Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
- (2018) Hong-Xia Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticle elasticity directs tumor uptake
- (2018) Peng Guo et al. Nature Communications
- Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
- (2018) Qiyi Feng et al. Scientific Reports
- Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C+ monocytes
- (2018) Li Liu et al. Theranostics
- A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
- (2018) Jonathan D. Finn et al. Cell Reports
- A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
- (2018) Jing Huang et al. Jove-Journal of Visualized Experiments
- In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
- (2018) Roselena Silvestri Schuh et al. JOURNAL OF CONTROLLED RELEASE
- Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway
- (2018) Jie Li et al. Frontiers in Pharmacology
- Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner?
- (2018) Brigitte Bauvois et al. Cancers
- Delivery technologies for genome editing
- (2017) Hao Yin et al. NATURE REVIEWS DRUG DISCOVERY
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- Applications of CRISPR technologies in research and beyond
- (2016) Rodolphe Barrangou et al. NATURE BIOTECHNOLOGY
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Microfluidic Synthesis of Hybrid Nanoparticles with Controlled Lipid Layers: Understanding Flexibility-Regulated Cell–Nanoparticle Interaction
- (2015) Lu Zhang et al. ACS Nano
- Biomedical applications of hydrogels: A review of patents and commercial products
- (2015) Enrica Caló et al. EUROPEAN POLYMER JOURNAL
- Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer
- (2015) Saverio Candido et al. Oncotarget
- Tunable Rigidity of (Polymeric Core)-(Lipid Shell) Nanoparticles for Regulated Cellular Uptake
- (2014) Jiashu Sun et al. ADVANCED MATERIALS
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
- (2014) John A Zuris et al. NATURE BIOTECHNOLOGY
- ICAM-1 as a molecular target for triple negative breast cancer
- (2014) P. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2
- (2013) G. Cheng et al. CANCER RESEARCH
- Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry
- (2013) Sandra Vranic et al. Particle and Fibre Toxicology
- Effect of Aspect Ratio and Deformability on Nanoparticle Extravasation through Nanopores
- (2012) Farrell R. Kersey et al. LANGMUIR
- Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
- (2012) Jason Park et al. NATURE MATERIALS
- Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions
- (2012) Alessandro Parodi et al. Nature Nanotechnology
- Lipocalin 2: A multifaceted modulator of human cancer
- (2011) Jiang Yang et al. CELL CYCLE
- Alginate: Properties and biomedical applications
- (2011) Kuen Yong Lee et al. PROGRESS IN POLYMER SCIENCE
- Relationships of lipocalin 2 with breast tumorigenesis and metastasis
- (2010) Xiaohong Leng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipocalin 2 promotes breast cancer progression
- (2009) J. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now